Davis KJ - Search Results

1

Masking in Pragmatic Trials: Who, What, and When to Blind.

Christian JB, Brouwer ES, Girman CJ, Bennett D, Davis KJ, Dreyer NA. Christian JB, et al. Among authors: davis kj. Ther Innov Regul Sci. 2020 Mar;54(2):431-436. doi: 10.1007/s43441-019-00073-7. Epub 2020 Jan 8. Ther Innov Regul Sci. 2020. PMID: 32072597

2

Methods for external control groups for single arm trials or long-term uncontrolled extensions to randomized clinical trials.

Seeger JD, Davis KJ, Iannacone MR, Zhou W, Dreyer N, Winterstein AG, Santanello N, Gertz B, Berlin JA. Seeger JD, et al. Among authors: davis kj. Pharmacoepidemiol Drug Saf. 2020 Nov;29(11):1382-1392. doi: 10.1002/pds.5141. Epub 2020 Oct 4. Pharmacoepidemiol Drug Saf. 2020. PMID: 32964514 Free PMC article. Review.

3

Uncontrolled Extensions of Clinical Trials and the Use of External Controls-Scoping Opportunities and Methods.

Wang CY, Berlin JA, Gertz B, Davis K, Li J, Dreyer NA, Zhou W, Seeger JD, Santanello N, Winterstein AG. Wang CY, et al. Clin Pharmacol Ther. 2022 Jan;111(1):187-199. doi: 10.1002/cpt.2346. Epub 2021 Aug 10. Clin Pharmacol Ther. 2022. PMID: 34165790 Free PMC article.

4

Landscape review of global real-world data sources for studying medication use in pregnancy and lactation that support regulatory decision making.

Davis K, Yost E, Brauneis J, Krumme A, Geldhof A, Tuck A, Sylvester S, Ephross S. Davis K, et al. Pharmacoepidemiol Drug Saf. 2024 Jan;33(1):e5711. doi: 10.1002/pds.5711. Epub 2023 Oct 18. Pharmacoepidemiol Drug Saf. 2024. PMID: 37850542 Review.

5

Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial data.

Sperrin M, Webb DJ, Patel P, Davis KJ, Collier S, Pate A, Leather DA, Pimenta JM. Sperrin M, et al. Among authors: davis kj. Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1369-1376. doi: 10.1002/pds.4883. Epub 2019 Aug 5. Pharmacoepidemiol Drug Saf. 2019. PMID: 31385428 Free PMC article.

6

Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study.

Suruki RY, Desai RJ, Davis KJ, Berlin JA, Gagne JJ. Suruki RY, et al. Among authors: davis kj. Rheumatology (Oxford). 2022 Aug 3;61(8):e236-e237. doi: 10.1093/rheumatology/keac157. Rheumatology (Oxford). 2022. PMID: 35333307 Free PMC article. No abstract available.

7

Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities.

Bauchau V, Davis K, Frise S, Jouquelet-Royer C, Wilkins J. Bauchau V, et al. Drug Saf. 2023 Apr;46(4):327-333. doi: 10.1007/s40264-023-01290-8. Epub 2023 Apr 11. Drug Saf. 2023. PMID: 37040044 Free PMC article.

8

Challenges of evaluating and modelling vaccination in emerging infectious diseases.

Madewell ZJ, Dean NE, Berlin JA, Coplan PM, Davis KJ, Struchiner CJ, Halloran ME. Madewell ZJ, et al. Among authors: davis kj. Epidemics. 2021 Dec;37:100506. doi: 10.1016/j.epidem.2021.100506. Epub 2021 Oct 5. Epidemics. 2021. PMID: 34628108 Free PMC article.

9

Fertiloscopy and its place in the gynaecologist's armamentarium.

McNamara S, Davis KJ, Reyftmann L. McNamara S, et al. Among authors: davis kj. Aust N Z J Obstet Gynaecol. 2024 Nov 13. doi: 10.1111/ajo.13894. Online ahead of print. Aust N Z J Obstet Gynaecol. 2024. PMID: 39535443

10

The global extent and severity of operational interactions between conflicting pinnipeds and fisheries.

Jackson J, Arlidge WNS, Oyanedel R, Davis KJ. Jackson J, et al. Among authors: davis kj. Nat Commun. 2024 Aug 28;15(1):7449. doi: 10.1038/s41467-024-51298-6. Nat Commun. 2024. PMID: 39198436 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters